Skip to content

Radiation Therapy Plan Quality Improvement Using Ideal Theoretical Isodose Distribution

Radiation Therapy Plan Quality Improvement Using Ideal Theoretical Isodose Distribution

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04782726
Enrollment
21
Registered
2021-03-04
Start date
2021-12-16
Completion date
2023-01-20
Last updated
2023-01-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Head and Neck Neoplasms

Brief summary

The researchers hope that based on the study findings future patients may benefit from a more precise radiation treatment plan that can be developed more quickly and thus decrease the time from Computerized Tomography Simulation to start of treatment.

Detailed description

As part of this study participants will receive the standard of care treatment for all head and neck cancer patients. The researchers plan to use a software program to see if it will assist in developing the best radiation treatment plan possible. The researchers will also measure the quality of each treatment plan so areas of improvement can be identified.

Interventions

OTHERSoftware Solution for Radiation Therapy Treatment

Software has been developed for individualized pre optimization evaluation of the patient anatomy and prescribed dose of radiation therapy.

OTHERRadiation therapy

Standard of Care planning for Radiation therapy is used to treat the subjects for head and neck cancer

Sponsors

The University of Texas Health Science Center at San Antonio
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age ≥ 18 years. * Ability to provide informed written consent in either English or Spanish. * Patient planned to undergo radiation therapy for Head and Neck Cancer.

Exclusion criteria

* Current pregnancy, as this is a contraindication to receiving radiation therapy. * History of prior radiotherapy to the head and neck. * Any condition or history as evidenced by patient record and/or self-report that, in the opinion of the investigator, would interfere with adherence to daily radiation therapy.

Design outcomes

Primary

MeasureTime frameDescription
Mean radiation dose to Organs at Risk (OAR)Baseline to last treatment (up to 33 treatments or about 7 weeks)Measurement of radiation dose to organs at risk. The goal is to maintain the PTV (Planning Target Volume) coverage while minimizing the dose to organs at risk (OARs).
Maximum radiation dose to Organs at Risk (OAR)Baseline to last treatment (up to 33 treatments or about 7 weeks)Measurement of maximum radiation dose to organs at risk. The goal is to maintain the PTV (Planning Target Volume) coverage while minimizing the dose to organs at risk (OARs).

Secondary

MeasureTime frameDescription
Time required to plan radiation therapy doseCT Simulation to first treatment (about 1 week)The time required with and without individualized pre optimization information will be recorded and compared to determine efficiency.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026